Access Bio Inc (950130) — Cash Flow-to-Debt Ratio
Access Bio Inc (950130) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2025, meaning its operating cash flow of ₩-9.16 Billion could theoretically repay 0% of its total liabilities (₩67.08 Billion) in one year. Explore Access Bio Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Access Bio Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Access Bio Inc across 13 annual periods. Also explore Access Bio Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Access Bio Inc (2012–2024)
Year-by-year debt coverage analysis for Access Bio Inc. For market capitalisation and broader financial context, see market cap of Access Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | ₩13.54 Million | ₩61.70 Million | ▲ +28427.1% |
| 2023 | 0.00x | ₩-80.57 Million | ₩104.00 Billion | ▼ -100.1% |
| 2022 | 1.38x | ₩291.33 Million | ₩210.97 Million | ▲ +31.3% |
| 2021 | 1.05x | ₩137.90 Million | ₩131.10 Million | ▼ -99.8% |
| 2020 | 462.09x | ₩36.72 Billion | ₩79.47 Million | ▲ +4368.9% |
| 2019 | -10.82x | ₩-422.24 Million | ₩39.01 Million | ▲ +90.3% |
| 2018 | -111.49x | ₩-5.73 Billion | ₩51.40 Million | ▲ +5.8% |
| 2017 | -118.30x | ₩-5.45 Billion | ₩46.03 Million | ▼ -244657.5% |
| 2016 | 0.05x | ₩2.11 Million | ₩43.68 Million | ▼ -92.8% |
| 2015 | 0.68x | ₩2.87 Billion | ₩4.24 Billion | ▲ +365.5% |
| 2014 | -0.25x | ₩-2.63 Billion | ₩10.35 Billion | ▼ -244.2% |
| 2013 | 0.18x | ₩1.59 Billion | ₩8.99 Billion | ▼ -29.4% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.38 Billion | — |